The number of private breast cancer surgery procedures in the UK has risen steadily since 2016, according to new analysis from the Private Healthcare Information Network (PHIN).
The data, released ahead of Breast Cancer Awareness Month in October, shows more than 64,900 procedures were carried out across 31,700 episodes between 2016 and early 2025. The most common interventions were axillary node biopsies, wide local excisions and mastectomies, often performed in combination within a single admission.
Patient demographics show the highest volumes among women aged 50–59, followed by those aged 40–49 and 60–69. PHIN noted that women in their 40s accounted for the second-largest share of private breast cancer surgeries, despite being below the current NHS screening threshold, which invites women from age 50.
The analysis also found that most patients had a median hospital stay of one night for one to three procedures, with longer admissions linked to more complex cases.
Dr Chris Smith-Brown, clinical advisor at PHIN (pictured), said: ‘This data on private breast cancer procedures is not just about numbers; it’s about the real impact on patients’ lives and the healthcare system. It highlights the need for early screening to treat breast cancer. A recent BMJ study by Swedish researchers found that missing the initial breast cancer screening increases mortality risk by 40%.’
He added: ‘The continued rise in private surgery and chemotherapy suggests growing patient confidence in the independent sector’s ability to treat breast cancer in the UK. Notably, even in light of the Ian Paterson scandal nearly 30 years ago and two additional inquests initiated earlier this month, patients continue to place their trust in the independent sector for their care.’
©2026 All rights reserved LaingBuisson
.){kind=link}